+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Should we routinely measure HVPG to assess response of primary prophylaxis in patients with cirrhosis? A decision analytic study



Should we routinely measure HVPG to assess response of primary prophylaxis in patients with cirrhosis? A decision analytic study



Hepatology 34(4 Pt 2): 534A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035727159

Download citation: RISBibTeXText


Related references

Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. European Journal of Internal Medicine 22(1): 5-7, 2011

Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!. European Journal of Internal Medicine 22(1): 1-4, 2011

Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study. Alimentary Pharmacology and Therapeutics 17(1): 145-153, 2003

Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: A decision analytical study. Alimentary Pharmacology & Therapeutics 17(1): 145-153, 2003

Decision analytic model comparing strategies for primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis. Gastroenterology 122(4 Suppl 1): A 656, 2002

Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: A decision analytic model. American Journal of Gastroenterology 98(4): 763-770, 2003

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. Liver International 39(4): 705-713, 2019

Hvpg measurements to guide secondary prophylaxis for variceal bleeding a decision analysis. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1414, 2003

O074 : A metabolomic study of serum from patients with cirrhosis identifies 2 metabolites that accurately predict the acute Hvpg response to -blocker therapy. Journal of Hepatology 62: S227-S228, 2015

Costs and clinical outcomes of primary prophylaxis of variceal bleeding in cirrhotics A decision analytic model. Hepatology 36(4 Part 2): 513A, 2002

Hemodynamic response to beta-blockers and prediction of clinical efficacy in the primary prophylaxis of variceal bleeding in patients with cirrhosis. Hepatology 38(4 Suppl 1): 296A, 2003

Should Antibiotic Prophylaxis Be Routinely Used in Patients with Antibody-Mediated Primary Immunodeficiency?. Journal of Allergy and Clinical Immunology. in Practice 6(2): 421-426, 2017

Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG. Scandinavian Journal of Gastroenterology 51(12): 1502-1506, 2016

The HVPG-response to pharmacological treatment of portal hypertension predicts prognosis and the risk of developing complications of cirrhosis. Journal of Hepatology 36(Suppl. 1): 15, 2002

Hepatic venous pressure gradient hvpg as a predictor of survival in patients with cirrhosis. Hepatology 12(4 Part 2): 850, 1990